 Raghav Productivity Enh LElectrodes & Refractories | Patent granted for ramming mass production process21 Aug 2026Regulatory Product Approval×3 | pending | ₹1,695 | 7,782 Cr | 135.8vs 49.1 | 27.4% | +11.0% |
 Titagarh Rail SystemsRailway Wagons | Vendor approval for 3-Phase Locomotive Traction Motor from Indian Railways19 Aug 2026Regulatory Product Approval | +1.8% — — | ₹845 | 11,378 Cr | 56.0 | 7.4% | +9.6% |
 Strides Pharma SciPharmaceuticals | Strides gets USFDA clearance for Bengaluru plant19 Aug 2026Regulatory Product Approval | +3.0% — — | ₹984 | 9,070 Cr | 13.8vs 28.5 | 16.6% | +8.4% |
 Centum ElectronicsAerospace & Defense | ECMS approval for Rs. 106 crore investment in Transducers and Filters18 Aug 2026Regulatory Product Approval | +0.4% — — | ₹3,445 | 5,078 Cr | — | 18.0% | +17.1% |
 PCBL ChemicalCarbon Black | PCBL gets ECMS approval for Acetylene Black Project worth Rs 329 cr18 Aug 2026Regulatory Product Approval | +2.9% — — | ₹318 | 12,503 Cr | 148.5 | 3.4% | -4.5% |
 Man Industries (I)Iron & Steel Products | Man Industries wins PML approval from QatarEnergy for LSAW pipes14 Aug 2026Regulatory Product Approval | +8.0% — — | ₹718 | 5,384 Cr | 24.5vs 16.9 | 9.8% | +38.8% |
 FDCPharmaceuticals | FDC subsidiary gets UK MHRA approval for Atropine eye drops13 Aug 2026Regulatory Product Approval | +0.3% — — | ₹348 | 5,667 Cr | 21.5vs 28.5 | 14.7% | +23.6% |
 Embassy DevelopmentsResidential Commercial Projects | Embassy Developments Q1 FY27 pre-sales up 338% YoY at about Rs 868 cr11 Aug 2026Regulatory Product Approval | -4.8% -3.1% — | ₹64.89 | 9,020 Cr | — | -5.8% | -70.8% |
 Apollo Micro SystemsAerospace & Defense | MD letter covers Premier Explosives acquisition and new defence wins8 Aug 2026Regulatory Product Approval | -3.5% -4.4% — | ₹382 | 13,645 Cr | 107.3vs 60.3 | 10.4% | +30.2% |
 Astrazeneca Pharma Ind LTPharmaceuticals | AstraZeneca India gets CDSCO nod for Enhertu additional indication8 Aug 2026Regulatory Product Approval×3 | -3.2% -8.5% — | ₹7,400 | 18,500 Cr | 119.4vs 28.5 | 25.0% | +3.5% |
 Guj Nar Val Fer & Chem LCommodity Chemicals | GNFC Gets Positive Rs 61 Crore Impact from Revised Urea Energy Norms1 Aug 2026Regulatory Product Approval | +1.8% +7.8% — | ₹584 | 8,589 Cr | 7.9vs 17.5 | 10.3% | +12.2% |
 Mas Financial ServNon Banking Financial Company (NBFC) | MAS Financial gets UIDAI approval for Aadhaar authentication services31 Jul 2026Regulatory Product Approval | -2.6% -4.5% — | ₹301 | 5,467 Cr | 14.0vs 17.5 | — | +13.0% |
 Alembic PharmaPharmaceuticals | Alembic Pharma gets USFDA nod for Prucalopride Tablets 1mg and 2mg28 Jul 2026Regulatory Product Approval×6 | -0.7% +2.4% — | ₹819 | 16,093 Cr | 24.0vs 28.5 | 11.2% | -3.3% |
 Kpi Green EnergyPower Generation | CEIG approval received for 100 MW solar project for MAHAGENCO in Maharashtra20 Jul 2026Regulatory Product Approval | -0.6% -4.6% -25.0% | ₹313 | 6,185 Cr | 11.8vs 22.3 | 8.8% | +25.5% |
 Natco PharmaPharmaceuticals | Natco gets tentative US FDA nod for Olaparib tablets18 Jul 2026Regulatory Product Approval | +1.7% -0.9% -7.0% | ₹883 | 15,799 Cr | 18.8vs 28.5 | 15.9% | -45.8% |
 Anand Rathi WealthFinancial Products Distributor | AR Wealth subsidiary gets IFSCA in-principle nod for fund management entity at GIFT City16 Jul 2026Regulatory Product Approval | -0.5% -1.3% +4.4% | ₹2,190 | 18,185 Cr | 44.6vs 21.6 | 48.6% | -3.2% |
 Choice InternationalHolding Company | SEBI approves Choice as Sponsor and Investment Manager for Category II AIF11 Jul 2026Regulatory Product Approval | -2.7% -3.0% -3.0% | ₹807 | 17,977 Cr | 65.7vs 12.8 | 13.9% | +11.8% |
 Punjab & Sind BankPublic Sector Bank | Punjab & Sind Bank gets IFSCA licence for GIFT IFSC banking unit8 Jul 2026Regulatory Product Approval×2 | -0.4% +0.1% -4.2% | ₹23.41 | 16,611 Cr | 22.1vs 15.1 | — | — |
 Computer Age MNGT SerDepositories Clearing Houses and Other Intermediaries | CAMS subsidiary gets IFSCA nod for KYC services at GIFT City3 Jul 2026Regulatory Product Approval | -1.3% -4.2% -1.0% | ₹753 | 18,673 Cr | 19.6 | 43.8% | +4.9% |
 Jubilant PharmovaPharmaceuticals | USFDA tentative approval for Pantoprazole oral suspension26 Jun 2026Regulatory Product Approval | +1.2% +0.9% +1.6% | ₹877 | 13,857 Cr | 39.5vs 28.5 | 4.7% | +16.5% |
 Jindal SawIron & Steel Products | Jindal Saw gets API license reinstated for seamless pipes25 Jun 2026Regulatory Product Approval×2 | +0.8% +1.2% -3.1% | ₹293 | 18,731 Cr | 23.1vs 16.9 | 6.8% | +9.4% |
 Concord BiotechPharmaceuticals | Concord Biotech clears Kenya and Uganda regulator inspections at Unit-II25 Jun 2026Regulatory Product Approval×4 | -1.6% -1.5% -1.9% | ₹1,560 | 16,320 Cr | 58.5vs 28.5 | 16.5% | +32.0% |
 Ola Electric Mobility2/3 Wheelers | Ola Electric gets BIS certification for indigenous 46100 LFP cell23 Jun 2026Regulatory Product Approval | +0.7% +4.4% -13.1% | ₹37.75 | 16,652 Cr | — | -37.0% | -61.6% |
 PuravankaraResidential Commercial Projects | Puravankara gets RERA registration for Miami By Purva project in Mumbai19 Jun 2026Regulatory Product Approval | -3.5% -4.1% -2.5% | ₹218 | 5,176 Cr | 14.9vs 22.3 | 3.7% | +133.1% |
 Gravita IndiaIndustrial Minerals | Gravita's Mundra plant gets LME brand accreditation for lead17 Jun 2026Regulatory Product Approval | +3.8% -1.8% +8.5% | ₹1,824 | 13,463 Cr | 35.0vs 18.6 | 17.2% | +13.3% |
 AvenuesaiFinancial Technology (Fintech) | Receipt of In-Principle Approval by Avenues World FZ LLC, Step Down Subsidiary Company from Central Bank of the UAE for a Retail Payment Services - Category III License4 Jun 2026Regulatory Product Approval | -1.4% +2.7% +21.2% | ₹15.25 | 5,326 Cr | 14.8vs 90.9 | 6.2% | +26.7% |
 Jeena Sikho LifecareWellness | Jeena Sikho Lifecare Limited Has Informed the Exchange About Receipt of NABH Accreditation for Bhopal Hospital.3 Jun 2026Regulatory Product Approval | -10.1% -12.8% -19.7% | ₹507 | 6,300 Cr | 26.6 | 52.2% | +13.5% |
 Bliss GVS PharmaPharmaceuticals | Bliss GVS Pharma Limited has informed the Exchange about Intimation of WHO-GMP Compliance of Manufacturing Facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).2 Jun 2026Regulatory Product Approval | +4.0% +0.2% +15.6% | ₹576 | 6,095 Cr | 51.7vs 28.5 | 15.1% | +5.2% |
 Corona RemediesPharmaceuticals | CORONA Remedies Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release - Receipt of EU-GMP Certificate".28 May 2026Regulatory Product Approval×2 | +0.5% +5.7% +17.1% | ₹2,147 | 13,132 Cr | 72.9vs 28.5 | 28.5% | -2.2% |
